Abstract:Ever since its emergence in 2019, COVID-19 has rapidly disseminated worldwide, engendering a pervasive pandemic that has profoundly impacted healthcare systems and the socio-economic milieu. A plethora of studies has been conducted targeting its pathogenic virus, SARS-CoV-2, to find ways to combat COVID-19. The ubiquitin-proteasome system (UPS) is widely recognized as a crucial mechanism that regulates human biological activities by maintaining protein homeostasis. Within the UPS, the ubiquitination and deubiquitination, two reversible modifications, of substrate proteins have been extensively studied and implicated in the pathogenesis of SARS-CoV-2. The regulation of E3 ubiquitin ligases and DUBs(Deubiquitinating enzymes), which are key enzymes involved in the two modification processes, determines the fate of substrate proteins. Proteins associated with the pathogenesis of SARS-CoV-2 may be retained, degraded, or even activated, thus affecting the ultimate outcome of the confrontation between SARS-CoV-2 and the host. In other words, the clash between SARS-CoV-2 and the host can be viewed as a battle for dominance over E3 ubiquitin ligases and DUBs, from the standpoint of ubiquitin modification regulation. This review primarily aims to clarify the mechanisms by which the virus utilizes host E3 ubiquitin ligases and DUBs, along with its own viral proteins that have similar enzyme activities, to facilitate invasion, replication, escape, and inflammation. We believe that gaining a better understanding of the role of E3 ubiquitin ligases and DUBs in COVID-19 can offer novel and valuable insights for developing antiviral therapies.

The Role of Deubiquitinases in Virus Replication and Host Innate Immune Response

Role of Virally-Encoded Deubiquitinating Enzymes in Regulation of the Virus Life Cycle

The Functional Deubiquitinating Enzymes in Control of Innate Antiviral Immunity

An Integrated View of Deubiquitinating Enzymes Involved in Type I Interferon Signaling, Host Defense and Antiviral Activities

Ubiquitination in Host Immune Response to Human Papillomavirus Infection

The Role of Deubiquitinases in Oncovirus and Host Interactions

Cellular Deubiquitylating Enzyme: A Regulatory Factor of Antiviral Innate Immunity

Viral deubiquitinases and innate antiviral immune response in livestock and poultry

The emerging role and therapeutic implications of bacterial and parasitic deubiquitinating enzymes

Specific Deubiquitinating Enzymes Promote Host Restriction Factors Against Hiv/Siv Viruses

Fine-tuning of antiviral innate immunity by ubiquitination

Viral deubiquitinating proteases and the promising strategies of their inhibition

Regulation of cellular innate antiviral signaling by ubiquitin modification.

Chemistry-based functional proteomics to identify novel deubiquitylating enzymes involved in viral infection.

Advance in Research on the Regulation of Innate Immune Response by Ubiquitination

Human DUBs' Gene Expression and Regulation in Antiviral Signaling in Response to Poly (I:C) Treatment.

Deubiquitylating Enzymes in Cancer and Immunity

Recent Progress of Deubiquitinating Enzymes in Human and Plant Pathogenic Fungi

Post-Translational Modifications of Deubiquitinating Enzymes: Expanding the Ubiquitin Code

Role of E3 ubiquitin ligases and deubiquitinating enzymes in SARS-CoV-2 infection

The Role of the Host Ubiquitin System in Promoting Replication of Emergent Viruses